Ticker: LPCN

Lipocine Inc. (NASDAQ: LPCN) has recently published its quarterly report for the period ended June 30, 2025. Here are key points extracted from the income statement and additional financial insights: Revenue: License Revenue: $500,000 recognized in Q2 2025 compared to $0 in Q2 2024. Royalty Rev...